JIECHENG MEDICAL
"Suzhou Jiecheng Medical Technology Co., Ltd." is a high-tech medical technology company with completely independent intellectual property rights and its patented technology is in a leading position in the world. The company was established in September 2009. The R&D team consists of Cardiologist Zhang Ji and several domestic and foreign R&D experts. The company's leading project is the development and production of the innovative "J-Valve Precision Positioning Heart Valve Implant System" techno... logy. "J-Valve Precise Positioning Heart Valve Implant System" is a minimally invasive surgical technique that eliminates the need to open a chest and eliminates extracorporeal blood circulation. It can significantly reduce patient's surgical trauma, shorten postoperative recovery time, reduce patient's pain, and reduce The requirements of the patient's physical condition, thereby expanding the range of application of the disease, improving the efficacy of treatment, reducing the cost of surgery, so that the majority of patients need to replace the heart valve can be treated. Other similar products can only be implanted into the heart through the use of imaging technology. The J-Valve system can completely rely on its own positioning device to assist doctors in performing valve replacement surgery, thereby reducing the risk of surgery, easier to operate and master, and simplifying the heart valve Replacement process. The above advantages will help reduce the overall cost of the country's health care system, promote the reform of the health care system, reduce medical costs, and save social medical resources. At the same time, drastic changes in the long-term dependence on
JIECHENG MEDICAL
Social Links:
Industry:
Health Care Manufacturing Medical Device
Founded:
2009-09-08
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.jiechengmedical.com
Total Employee:
101+
Status:
Active
Contact:
+86 512 63179788
Email Addresses:
[email protected]
Total Funding:
110 M CNY
Similar Organizations
Aston Medical
Aston Medical specializes in the design, manufacture, and distribution of innovative orthopedic prostheses.
Bedfont Scientific
Bedfont Scientific designs and manufactures breath and gas analysis equipment.
Breath Home
Breath Home engages in the development and production of respiratory diagnostics, monitoring and treatment equipment.
BRH Medical
BRH Medical specializes in developing and marketing medical devices for the treatment of chronic wounds.
Eversens
Eversens is a company specializing in the design, development, and manufacturing of non-invasive clinical systems.
Finesse Medical
Finesse Medical specialises in the development, Manufacture and Marketing of a range of advanced technologies.
Haize Medical
Haize Medical focuses on the R&D, production and sales of medical devices and equipment.
LeapMed
LeapMed is a manufacturer and supplier of ultrasound biopsy kits.
leye
leye focuses on the development and production of ophthalmic products.
Masterson Industries
Masterson Industries specializes in the commercial production of microgravity-enabled materials.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
nt-trading
nt-trading is focuses on the development and the production of premium products in the field of dental implant technology.
Simwon Tech
Simwon Tech specializes in the development of products containing people-centered social values.
Singular Medical
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management products.
Soundbite Medical Solutions
Soundbite is a medical device company developing products in the field of vessel preparation for management and treatment.
Tata Medical & Diagnostics
Tata Medical & Diagnostics develop leading-edge, patient-centric solutions to provide reliable and accessible healthcare to all.
Investors List
Ningbo Meishan Free Trade Port Zone Yuanlong Investment Management
Ningbo Meishan Free Trade Port Zone Yuanlong Investment Management investment in Series D - Jiecheng Medical
Tongsheng Shengming Kexue Hong Kong
Tongsheng Shengming Kexue Hong Kong investment in Series C - Jiecheng Medical
Suzhou Jiexu Management Consulting
Suzhou Jiexu Management Consulting investment in Series C - Jiecheng Medical
Shanghai Jiepo Business Consulting
Shanghai Jiepo Business Consulting investment in Series B - Jiecheng Medical
6 Dimensions Capital
6 Dimensions Capital investment in Series A - Jiecheng Medical
Official Site Inspections
http://www.jiechengmedical.com
- Host name: 123.59.154.172
- IP address: 123.59.154.172
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai
More informations about "Jiecheng Medical"
Suzhou Jiecheng Medical Technology Co., Ltd-About Us
Suzhou Jiecheng Medical Technology Co., Ltd. was established in September 2009. It is a high-tech enterprise focusing on the R&D and manufacturing of high-end cardiovascular medical …See details»
苏州杰成医疗科技有限公司-J-VALVE® TA,J-VALVE® TF
杰成医疗的核心产品“J-Valve 经心尖入路心脏瓣膜植入系统”于 2017 年获得NMPA 批准上市See details»
Jiecheng Medical - Crunchbase Company Profile
Contact Email [email protected] Phone Number +86 512 63179788 "Suzhou Jiecheng Medical Technology Co., Ltd." is a high-tech medical …See details»
苏州杰成医疗科技有限公司-关于我们 - Jiecheng Medical
苏州杰成医疗科技有限公司 关于我们 杰成医疗的核心产品“J-Valve 经心尖入路心脏瓣膜植入系统”于 2017 年获得NMPA 批准上市See details»
苏州杰成医疗科技有限公司-联系我们 - jiechengmedical.com
地址:苏州工业园区星湖街218号生物医药产业园C21楼. 电话:+86-512-63036188 传真:+86-512-63036288 邮箱:[email protected]. 邮编:215123See details»
Suzhou Jiecheng Medical Technology Co., Ltd. (A Gensis ... - LinkedIn
Suzhou Jiecheng Medical Technology Co., Ltd. (A Gensis Medtech Company ) | 87 followers on LinkedIn. 苏州杰成医疗科技有限公司的愿景是:助力医生, 救治病人 (Partnering with ...See details»
Suzhou Jiecheng Medical Technologies, Inc. - Drug pipelines, …
Explore Suzhou Jiecheng Medical Technologies, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
Suzhou Jiecheng Medical Technology Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Suzhou Jiecheng Medical Technology Co., Ltd. of Suzhou, Jiangsu. Get the latest business insights …See details»
Suzhou Jiecheng Medical Technology Co., Ltd. - preqin.com
Established in 2009 and based in Suzhou, China, Suzhou Jiecheng Medical Technology Co., Ltd. is a healthcare company that focuses on development, production ...See details»
Jiecheng Medical | Day of Difference
Suzhou Jiecheng Medical Technology Co., Ltd. Company Profile. https://www.dnb.com/business-directory/company-profiles.suzhou_jiecheng_medical_technology_co_ltd ...See details»
苏州杰成医疗科技有限公司: 药物管线,专利,临床试验 - 智慧芽新 …
了解苏州杰成医疗科技有限公司公司的药物管线,治疗领域,技术平台,以及它的3篇新闻。See details»
杰成医疗-动脉网 - vbdata.cn
Sep 8, 2009 苏州杰成医疗科技有限公司是一家拥有完全自主知识产权的微创医疗技术公司,成立于2009年9月,研发团队由心脏外科专家张极医生和多名外籍资深专业人士组成。公司的主导 …See details»
苏州杰成医疗科技有限公司-第22届中国南方国际心血管病学术会议
苏州杰成医疗科技有限公司是一家专注于高端心血管医疗器械研发与制造的高新技术企业。拥有多项国际pct发明专利,创新 ...See details»
Jiecheng Medical Technology - Company Profile - Tracxn
Oct 22, 2024 Jiecheng Medical Technology ranks 76th among 108 active competitors. 50 of its competitors are funded while 27 have exited. Overall, Jiecheng Medical Technology and its …See details»
杰成医疗_医疗项目_动脉网数据 - vbdata.cn
动脉网数据库,苏州杰成医疗科技有限公司是一家拥有完全自主知识产权的微创医疗技术公司,成立于2009年9月,研发团队由心脏外科专家张极医生和多名外籍资深专业人士组成。公司的主 …See details»
Suzhou Jiecheng Medical Technology Co., Ltd-Recruiting talents …
Suzhou Jiecheng Medical Technology Co., Ltd Recruiting talents and talents JAC's core product, the J-Valve Transapical Heart Valve Implant System, was approved by the NMPA in 2017.See details»
杰成医疗:J-Valve系统微创治疗主动脉瓣关闭不全或狭窄_心脏
Sep 7, 2019 经导管主动脉瓣膜置换术(TAVR)这一微创介入手术技术的出现为这类患者带来了希望。 为解决这一难题,张极博士及其团队研发出J-Valve介入人工生物瓣膜,该产品适用于 …See details»
苏州杰成医疗科技有限公司-校园招聘 - jiechengmedical.com
苏州杰成医疗科技有限公司 校园招聘 杰成医疗的核心产品“J-Valve 经心尖入路心脏瓣膜植入系统”于 2017 年获得NMPA 批准上市See details»
The J-Valve system (JieCheng Medical Technology Corporation Ltd ...
Currently, the J-valve system can also be used for valve-in-valve treatment in some high-risk patients with biological valvular destruction. Yuntao Lu et al. reported 26 patients who …See details»